Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit

S0597 is a novel glucocorticosteroid that was formulated as an intranasal spray to treat seasonal allergic rhinitis (SAR). In a previous phase 2 study, doses of 100 to 400 μg twice daily were well tolerated and more effective than placebo for improving nasal symptoms induced by grass pollen.

http://ift.tt/2ciJJ7J